Roman Butler Fullerton & CO Moderna, Inc. Transaction History

Roman Butler Fullerton & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$126.46 - $235.05 $160,604 - $298,513	-1,270 Closed	0 $0
Q4 2021 Jan 24, 2022	SELL	$225.82 - $368.51 $22,582 - $36,851	-100 Reduced 7.3%	1,270 $323,000
Q3 2021 Nov 10, 2021	SELL	$221.9 - $484.47 $22,190 - $48,447	-100 Reduced 6.8%	1,370 $459,000
Q1 2021 Apr 22, 2021	BUY	$109.18 - $185.98 $160,494 - $273,390	1,470 New	1,470 $235,000

953

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.9B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Roman Butler Fullerton & CO, based on Form 13F filings with the SEC.

Stay updated on Roman Butler Fullerton & CO with notifications on news.